{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidd374omjjzazhghwpsmflgx74mmlzhcsyc354wii2ymh7yosizg4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkixx5h7zzo2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaiakj5b5funmw2d4m2u22dp3t2vwgc3wusi26n4375yn3qfvqyeu"
    },
    "mimeType": "image/jpeg",
    "size": 212374
  },
  "path": "/2026/04/27/erasca-pancreatic-cancer-study-results/?utm_campaign=rss",
  "publishedAt": "2026-04-27T20:01:11.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "Cancer",
    "drug development",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer exceeded its expectations.",
  "title": "STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy",
  "updatedAt": "2026-04-27T20:31:46.000Z"
}